C O N M E D Cp (CNMD) 40.99 $CNMD New Strong Se
Post# of 273258
Posted On: 09/02/2016 11:02:12 PM
C O N M E D Cp (CNMD) 40.99 $CNMD
New Strong Sell Stocks for September 2nd
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 9:55AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
GEO: 20.85 (+1.17), CNMD: 40.99 (+0.43), BGC: 16.36 (+0.25), GIII: 32.88 (+0.14), CCU: 21.60 (+0.71)
CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference
BusinessWire - Wed Aug 31, 3:01PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the Morgan Stanley Global Healthcare Conference at 9:20 a.m. ET on Wednesday, September 14, 2016 in New York, NY.
CNMD: 40.99 (+0.43), MS: 31.89 (-0.02)
CONMED Corporation Announces Quarterly Cash Dividend
BusinessWire - Thu Aug 25, 3:01PM CDT
CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2016 to all shareholders of record as of September 15, 2016.
CNMD: 40.99 (+0.43)
Downgrade Alert for Conmed (CNMD)
Comtex SmarTrend(R) - Fri Jul 29, 3:52AM CDT
Conmed (NASDAQ:CNMD) was downgraded from Outperform to Market Perform at Leerink today. The stock closed yesterday at $39.92 on volume of 1.6 million shares, above average daily volume of 188,000. CONMED Corporation provides orthopedic products, specializing in arthroscopy and powered surgical instruments. The Company develops, manufactures, and supplies surgical instruments and systems used in a range of surgical procedures. CONMED's products include arthroscopic surgery devices and powered surgical instruments, electrosurgery systems, and ECG electrodes for heart monitoring.
CNMD: 40.99 (+0.43)
CONMED (CNMD) Earnings & Sales Beat in Q2, '16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 8:45AM CDT
CONMED Corporation (CNMD) reported second-quarter 2016 adjusted earnings of 47 cents per share, surpassing the Zacks Consensus Estimate.
ABC: 87.44 (+0.29), BCR: 221.21 (-0.29), ALGN: 95.78 (+2.02), CNMD: 40.99 (+0.43)
CONMED Corporation Announces Second Quarter 2016 Financial Results
BusinessWire - Wed Jul 27, 3:01PM CDT
CONMED Corporation (Nasdaq:CNMD) today announced financial results for the second quarter ended June 30, 2016.
CNMD: 40.99 (+0.43)
DENTSPLY Sirona (XRAY): Q1 Strong, Expansion on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
On Jun 17, we issued an updated research report on NY-based DENTSPLY Sirona Inc. (XRAY).
HYH: 36.57 (+0.32), BCR: 221.21 (-0.29), CNMD: 40.99 (+0.43), XRAY: 61.70 (+0.05)
Global Sports Medicine Market 2016-2020 - Key Vendors are Arthrex, CONMED, DePuy Synthes, Smith & Nephew & Stryker
GlobeNewswire - Wed Jun 15, 8:19AM CDT
Research and Markets has announced the addition of the "Global Sports Medicine Market 2016-2020" report to their offering.
SNN: 33.47 (+0.77), CNMD: 40.99 (+0.43)
Patterson Companies (PDCO) Q4 Earnings Top, Sales Strong
Zacks Equity Research - Zacks Investment Research - Thu May 26, 9:02AM CDT
Patterson Companies Inc. (PDCO) reported adjusted earnings of 77 cents per share from continuing operations that beat the Zacks Consensus Estimate by a penny.
HYH: 36.57 (+0.32), BCR: 221.21 (-0.29), CNMD: 40.99 (+0.43), PDCO: 46.89 (+0.86)
Veeva Systems (VEEV) Q1 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 9:26AM CDT
Notably, Veeva (VEEV) posted an average positive surprise of 15.98% over the last four quarters.
VEEV: 40.74 (+0.51), AIRM: 35.79 (+0.90), CNMD: 40.99 (+0.43), LH: 137.71 (+1.58)
Can Patterson Companies (PDCO) Surprise in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:32AM CDT
Patterson Companies Inc. (PDCO) is set to announce fourth-quarter fiscal 2016 earnings on May 26.
AIRM: 35.79 (+0.90), CNMD: 40.99 (+0.43), PDCO: 46.89 (+0.86), LH: 137.71 (+1.58)
Becton, Dickinson's (BDX) MAX Vaginal Panel Gets CE Mark
Zacks Equity Research - Zacks Investment Research - Mon May 16, 6:42AM CDT
Becton, Dickinson and Company (BDX) recently announced the receipt of CE marking for its BD MAX Vaginal Panel.
BDX: 177.32 (+0.30), BCR: 221.21 (-0.29), MDT: 87.32 (+0.34), CNMD: 40.99 (+0.43)
DENTSPLY (XRAY) Tops Q1 Earnings & Sales, View Positive
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:19AM CDT
DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings of 69 cents per share in the first quarter of 2016 which beat the Zacks Consensus Estimate by 6 cents.
BCR: 221.21 (-0.29), VWR: 27.79 (+0.04), CNMD: 40.99 (+0.43), XRAY: 61.70 (+0.05)
Becton, Dickinson (BDX) Beats Q2 Earnings on Solid Sales
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:21AM CDT
Becton, Dickinson and Company (BDX) reported second-quarter fiscal 2016 earnings of $2.18 per share, which beat the Zacks Consensus Estimate by 17 cents.
BDX: 177.32 (+0.30), BCR: 221.21 (-0.29), ALGN: 95.78 (+2.02), CNMD: 40.99 (+0.43)
Conmed reports 1Q loss
Automated Insights - Wed Apr 27, 4:46PM CDT
UTICA, N.Y. (AP) _ Conmed Corp. (CNMD) on Wednesday reported a first-quarter loss of $2.3 million, after reporting a profit in the same period a year earlier.
CNMD: 40.99 (+0.43)
CONMED Corporation Announces First Quarter 2016 Financial Results
BusinessWire - Wed Apr 27, 3:01PM CDT
CONMED Corporation (Nasdaq:CNMD) today announced financial results for the first quarter ended March 31, 2016.
CNMD: 40.99 (+0.43)
CONMED Corporation to Present at the Deutsche Bank 41st Annual Health Care Conference
BusinessWire - Wed Apr 13, 3:05PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the Deutsche Bank 41st Annual Health Care Conference at 2:10 p.m. ET on Thursday, May 5, 2016 in Boston, MA.
CNMD: 40.99 (+0.43), DB: 14.90 (+0.21)
CONMED Corporation to Announce First Quarter 2016 Financial Results on April 27, 2016
BusinessWire - Wed Apr 06, 3:05PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the first quarter of fiscal year 2016 after the market close on Wednesday, April 27, 2016. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
CNMD: 40.99 (+0.43)
CONMED Corporation to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
BusinessWire - Mon Feb 01, 3:01PM CST
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the LEERINK Partners 5th Annual Global Healthcare Conference at 8:05 a.m. ET on Thursday, February 11, 2016 in New York, NY.
CNMD: 40.99 (+0.43)
New Strong Sell Stocks for September 2nd
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 9:55AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
GEO: 20.85 (+1.17), CNMD: 40.99 (+0.43), BGC: 16.36 (+0.25), GIII: 32.88 (+0.14), CCU: 21.60 (+0.71)
CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference
BusinessWire - Wed Aug 31, 3:01PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the Morgan Stanley Global Healthcare Conference at 9:20 a.m. ET on Wednesday, September 14, 2016 in New York, NY.
CNMD: 40.99 (+0.43), MS: 31.89 (-0.02)
CONMED Corporation Announces Quarterly Cash Dividend
BusinessWire - Thu Aug 25, 3:01PM CDT
CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2016 to all shareholders of record as of September 15, 2016.
CNMD: 40.99 (+0.43)
Downgrade Alert for Conmed (CNMD)
Comtex SmarTrend(R) - Fri Jul 29, 3:52AM CDT
Conmed (NASDAQ:CNMD) was downgraded from Outperform to Market Perform at Leerink today. The stock closed yesterday at $39.92 on volume of 1.6 million shares, above average daily volume of 188,000. CONMED Corporation provides orthopedic products, specializing in arthroscopy and powered surgical instruments. The Company develops, manufactures, and supplies surgical instruments and systems used in a range of surgical procedures. CONMED's products include arthroscopic surgery devices and powered surgical instruments, electrosurgery systems, and ECG electrodes for heart monitoring.
CNMD: 40.99 (+0.43)
CONMED (CNMD) Earnings & Sales Beat in Q2, '16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 8:45AM CDT
CONMED Corporation (CNMD) reported second-quarter 2016 adjusted earnings of 47 cents per share, surpassing the Zacks Consensus Estimate.
ABC: 87.44 (+0.29), BCR: 221.21 (-0.29), ALGN: 95.78 (+2.02), CNMD: 40.99 (+0.43)
CONMED Corporation Announces Second Quarter 2016 Financial Results
BusinessWire - Wed Jul 27, 3:01PM CDT
CONMED Corporation (Nasdaq:CNMD) today announced financial results for the second quarter ended June 30, 2016.
CNMD: 40.99 (+0.43)
DENTSPLY Sirona (XRAY): Q1 Strong, Expansion on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
On Jun 17, we issued an updated research report on NY-based DENTSPLY Sirona Inc. (XRAY).
HYH: 36.57 (+0.32), BCR: 221.21 (-0.29), CNMD: 40.99 (+0.43), XRAY: 61.70 (+0.05)
Global Sports Medicine Market 2016-2020 - Key Vendors are Arthrex, CONMED, DePuy Synthes, Smith & Nephew & Stryker
GlobeNewswire - Wed Jun 15, 8:19AM CDT
Research and Markets has announced the addition of the "Global Sports Medicine Market 2016-2020" report to their offering.
SNN: 33.47 (+0.77), CNMD: 40.99 (+0.43)
Patterson Companies (PDCO) Q4 Earnings Top, Sales Strong
Zacks Equity Research - Zacks Investment Research - Thu May 26, 9:02AM CDT
Patterson Companies Inc. (PDCO) reported adjusted earnings of 77 cents per share from continuing operations that beat the Zacks Consensus Estimate by a penny.
HYH: 36.57 (+0.32), BCR: 221.21 (-0.29), CNMD: 40.99 (+0.43), PDCO: 46.89 (+0.86)
Veeva Systems (VEEV) Q1 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 9:26AM CDT
Notably, Veeva (VEEV) posted an average positive surprise of 15.98% over the last four quarters.
VEEV: 40.74 (+0.51), AIRM: 35.79 (+0.90), CNMD: 40.99 (+0.43), LH: 137.71 (+1.58)
Can Patterson Companies (PDCO) Surprise in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:32AM CDT
Patterson Companies Inc. (PDCO) is set to announce fourth-quarter fiscal 2016 earnings on May 26.
AIRM: 35.79 (+0.90), CNMD: 40.99 (+0.43), PDCO: 46.89 (+0.86), LH: 137.71 (+1.58)
Becton, Dickinson's (BDX) MAX Vaginal Panel Gets CE Mark
Zacks Equity Research - Zacks Investment Research - Mon May 16, 6:42AM CDT
Becton, Dickinson and Company (BDX) recently announced the receipt of CE marking for its BD MAX Vaginal Panel.
BDX: 177.32 (+0.30), BCR: 221.21 (-0.29), MDT: 87.32 (+0.34), CNMD: 40.99 (+0.43)
DENTSPLY (XRAY) Tops Q1 Earnings & Sales, View Positive
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:19AM CDT
DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings of 69 cents per share in the first quarter of 2016 which beat the Zacks Consensus Estimate by 6 cents.
BCR: 221.21 (-0.29), VWR: 27.79 (+0.04), CNMD: 40.99 (+0.43), XRAY: 61.70 (+0.05)
Becton, Dickinson (BDX) Beats Q2 Earnings on Solid Sales
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:21AM CDT
Becton, Dickinson and Company (BDX) reported second-quarter fiscal 2016 earnings of $2.18 per share, which beat the Zacks Consensus Estimate by 17 cents.
BDX: 177.32 (+0.30), BCR: 221.21 (-0.29), ALGN: 95.78 (+2.02), CNMD: 40.99 (+0.43)
Conmed reports 1Q loss
Automated Insights - Wed Apr 27, 4:46PM CDT
UTICA, N.Y. (AP) _ Conmed Corp. (CNMD) on Wednesday reported a first-quarter loss of $2.3 million, after reporting a profit in the same period a year earlier.
CNMD: 40.99 (+0.43)
CONMED Corporation Announces First Quarter 2016 Financial Results
BusinessWire - Wed Apr 27, 3:01PM CDT
CONMED Corporation (Nasdaq:CNMD) today announced financial results for the first quarter ended March 31, 2016.
CNMD: 40.99 (+0.43)
CONMED Corporation to Present at the Deutsche Bank 41st Annual Health Care Conference
BusinessWire - Wed Apr 13, 3:05PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the Deutsche Bank 41st Annual Health Care Conference at 2:10 p.m. ET on Thursday, May 5, 2016 in Boston, MA.
CNMD: 40.99 (+0.43), DB: 14.90 (+0.21)
CONMED Corporation to Announce First Quarter 2016 Financial Results on April 27, 2016
BusinessWire - Wed Apr 06, 3:05PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the first quarter of fiscal year 2016 after the market close on Wednesday, April 27, 2016. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
CNMD: 40.99 (+0.43)
CONMED Corporation to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
BusinessWire - Mon Feb 01, 3:01PM CST
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the LEERINK Partners 5th Annual Global Healthcare Conference at 8:05 a.m. ET on Thursday, February 11, 2016 in New York, NY.
CNMD: 40.99 (+0.43)
(0)
(0)Scroll down for more posts ▼